110 related articles for article (PubMed ID: 23727519)
21. An assessment of gynecological cytology screening practices among health care providers nationwide.
Darwish-Yassine M; Garvin AD; Johnston CM; Zoschnick L; Conners A; Laing S; Wojcik C
Arch Pathol Lab Med; 2015 May; 139(5):650-5. PubMed ID: 25927148
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
23. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
25. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
26. Sensitivity of HPV tests on stained vs. unstained cervical smears.
de Lang A; Wilander E
Acta Cytol; 2005; 49(6):595-9. PubMed ID: 16450897
[TBL] [Abstract][Full Text] [Related]
27. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
[TBL] [Abstract][Full Text] [Related]
28. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
Scott DR; Hagmar B; Maddox P; Hjerpe A; Dillner J; Cuzick J; Sherman ME; Stoler MH; Kurman RJ; Kiviat NB; Manos MM; Schiffman M
Cancer; 2002 Feb; 96(1):14-20. PubMed ID: 11836698
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
Qin J; Saraiya M; Martinez G; Sawaya GF
JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
[TBL] [Abstract][Full Text] [Related]
32. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of human papillomavirus DNA types 16 and 18 (HPV-16/18) in cervical smears as compared to cytological findings.
Köchel HG; Teichmann A; Eckardt N; Arendt P; Kuhn W; Thomssen R
Int J Gynaecol Obstet; 1990 Feb; 31(2):145-52. PubMed ID: 1968861
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions.
Nuovo GJ; Walsh LL; Gentile JL; Blanco JS; Koulos J; Heimann A
Am J Clin Pathol; 1991 Oct; 96(4):544-8. PubMed ID: 1654025
[TBL] [Abstract][Full Text] [Related]
35. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
Wong ELY; Cheung AWL; Huang F; Chor JSY
Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.
Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF
Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588
[TBL] [Abstract][Full Text] [Related]
37. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
Zhao C; Li Z; Nayar R; Levi AW; Winkler BA; Moriarty AT; Barkan GA; Rao J; Miller F; Fan F; Zhou Z; Si Q; Fischer AH; Sturgis CD; Jing X; Marshall CB; Witt BL; Birdsong GG; Crothers BA
Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
[TBL] [Abstract][Full Text] [Related]
38. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system.
Becerra-Culqui TA; Lonky NM; Chen Q; Chao CR
Am J Obstet Gynecol; 2018 Apr; 218(4):429.e1-429.e9. PubMed ID: 29277629
[TBL] [Abstract][Full Text] [Related]
39. Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine.
Higgins LM; Dirksing KN; Ding L; Morrow CD; Widdice LA; Kahn JA
Hum Vaccin Immunother; 2016 Jun; 12(6):1498-503. PubMed ID: 26934107
[TBL] [Abstract][Full Text] [Related]
40. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?
Baer A; Kiviat NB; Kulasingam S; Mao C; Kuypers J; Koutsky LA
Obstet Gynecol; 2002 Jun; 99(6):1053-9. PubMed ID: 12052599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
